Table 1.
Demographic and Clinical Characteristics of Individuals in the Early Course of Schizophrenia Randomized to a Trial of Cognitive Enhancement Therapy (CET) or Enriched Supportive Therapy (EST)
| Cognitive enhancement therapy (n = 25) |
Enriched supportive therapy (n = 16) |
||||
|---|---|---|---|---|---|
| Variable | M / N | SD / % | M / N | SD / % | p a |
| Age | 24.95 | 5.16 | 26.13 | 5.29 | .485 |
| Male | 14 | 56% | 12 | 75% | .368 |
| White | 17 | 68% | 11 | 69% | .500 |
| Completed college | 8 | 32% | 6 | 38% | .980 |
| Employed | 8 | 32% | 6 | 38% | .980 |
| Schizophrenia diagnosis | 16 | 64% | 10 | 62% | 1.00 |
| Illness duration (years) | 3.36 | 2.45 | 2.97 | 1.84 | .584 |
| IQ | 97.56 | 8.29 | 101.00 | 7.38 | .184 |
| BPRS total | 39.08 | 8.93 | 41.00 | 12.23 | .565 |
| Antipsychotic dose (cpz) | 374.67 | 266.28 | 420.10 | 297.47 | .613 |
| Medication adherent | 23 | 92% | 14 | 88% | 1.00 |
Note. BPRS = Brief Psychiatric Rating Scale, cpz = chlorpromazine equivalence
a
Chi-square test or independent t-test, two-tailed, for significant differences between CET and EST participants.